Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Anfinsen Dogma: Intriguing Details Sixty-Five Years Later.
Gambardella G, Notari S, Cavaterra D, Iavarone F, Castagnola M, Bocedi A, Ricci G. Gambardella G, et al. Among authors: notari s. Int J Mol Sci. 2022 Jul 14;23(14):7759. doi: 10.3390/ijms23147759. Int J Mol Sci. 2022. PMID: 35887107 Free PMC article.
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor.
Altintas DM, Gallo S, Basilico C, Cerqua M, Bocedi A, Vitacolonna A, Botti O, Casanova E, Rancati I, Milanese C, Notari S, Gambardella G, Ricci G, Mastroberardino PG, Boccaccio C, Crepaldi T, Comoglio PM. Altintas DM, et al. Among authors: notari s. Int J Mol Sci. 2022 Oct 17;23(20):12427. doi: 10.3390/ijms232012427. Int J Mol Sci. 2022. PMID: 36293286 Free PMC article.
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, Cimini E, Notari S, Bordoni V, Mastrorosa I, Giancola ML, Vergori A, Tempestilli M, Vita S, Mariotti D, Rosati S, Lalle E, Meschi S, Colavita F, Garbuglia AR, Girardi E, Nicastri E, Antinori A, Agrati C. Casetti R, et al. Among authors: notari s. Int Immunopharmacol. 2025 Jan 19;148:113934. doi: 10.1016/j.intimp.2024.113934. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39832460
Vδ2 T-cells response in people with Mpox infection: a three-month longitudinal assessment.
Cimini E, Tartaglia E, Messina F, Coppola A, Mazzotta V, Tempestilli M, Matusali G, Notari S, Mondi A, Prota G, Oliva A, Fontana C, Girardi E, Maggi F, Antinori A. Cimini E, et al. Among authors: notari s. Emerg Microbes Infect. 2025 Jan 16:2455585. doi: 10.1080/22221751.2025.2455585. Online ahead of print. Emerg Microbes Infect. 2025. PMID: 39817429 Free article.
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, Palazzi R, Paulicelli J, Mariotti D, Mazzotta V, Notari S, Casetti R, Francalancia M, Rosati S, D'Abramo A, Mija C, Mencarini P, Milozzi E, Caraffa E, Sica S, Metafuni E, Sorà F, Rago A, Siniscalchi A, Abruzzese E, Garzia M, Luzi G, Battistini R, Prosperini L, Cingolani A, Girardi E, Maggi F, Antinori A; OCTOPUS Study Group. Vergori A, et al. Among authors: notari s. Vaccines (Basel). 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784. Vaccines (Basel). 2024. PMID: 39066422 Free PMC article.
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
Matusali G, Vergori A, Cimini E, Mariotti D, Mazzotta V, Lepri AC, Colavita F, Gagliardini R, Notari S, Meschi S, Fusto M, Tartaglia E, Girardi E, Maggi F, Antinori A; HIV‐VAC Study Group. Matusali G, et al. Among authors: notari s. J Med Virol. 2024 Apr;96(4):e29598. doi: 10.1002/jmv.29598. J Med Virol. 2024. PMID: 38624044
104 results